Toshihiko Matsumoto Selected Research

Fatty Liver

9/2021	Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose.
11/2020	Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model.
1/2017	Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver.
7/2010	Medaka as a model for human nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiko Matsumoto Research Topics

Disease

27	Substance-Related Disorders (Drug Abuse) 01/2022 - 02/2005
19	Neoplasms (Cancer) 11/2022 - 11/2003
13	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 06/2013
8	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 02/2015
7	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 06/2013
6	Mental Disorders (Mental Disorder) 01/2022 - 01/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2011
6	Hypoxia (Hypoxemia) 05/2020 - 03/2016
5	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2020
5	Psychotic Disorders (Schizoaffective Disorder) 12/2020 - 10/2007
5	Fibrosis (Cirrhosis) 11/2020 - 01/2016
4	Alcoholism (Alcohol Abuse) 01/2022 - 02/2006
4	Fatty Liver 09/2021 - 07/2010
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2003
3	Liver Diseases (Liver Disease) 05/2020 - 01/2019
3	Poisoning 01/2016 - 01/2008
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2014 - 02/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 05/2020
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 01/2021
2	Marijuana Abuse (Cannabis Abuse) 01/2022 - 12/2020
2	Non-alcoholic Fatty Liver Disease 09/2021 - 04/2011
2	Genomic Instability 05/2019 - 01/2018
2	Esophageal Neoplasms (Esophageal Cancer) 09/2017 - 02/2017
2	Hemorrhage 09/2017 - 05/2010
2	Alcohol-Related Disorders 02/2014 - 12/2012
1	Neuroinflammatory Diseases 01/2022
1	Anxiety Disorders (Anxiety Disorder) 04/2021
1	Febrile Neutropenia 02/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2021
1	Pancreatic Diseases (Pancreatic Disease) 01/2021
1	Neutropenia 12/2020

Drug/Important Bio-Agent (IBA)

23	Pharmaceutical PreparationsIBA 01/2022 - 06/2005
12	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 02/2005
8	Chelating AgentsIBA 05/2022 - 05/2014
8	IronIBA 05/2022 - 05/2014
7	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 03/2018
6	Deferoxamine (Desferal)FDA LinkGeneric 05/2022 - 05/2014
5	Therapeutic UsesIBA 01/2022 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2018
5	Deferasirox FDA Link 07/2020 - 01/2016
5	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 05/2016
4	BenzodiazepinesIBA 01/2022 - 04/2015
4	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 12/2010
3	Anti-Anxiety Agents (Anxiolytics)IBA 04/2021 - 12/2010
3	Bevacizumab (Avastin)FDA Link 02/2021 - 01/2017
3	hydrogen sulfite (bisulfite)IBA 01/2021 - 03/2018
3	Amino Acids FDA Link 11/2020 - 05/2016
3	Messenger RNA (mRNA)IBA 11/2020 - 03/2014
3	Choline (Choline Chloride)IBA 11/2020 - 05/2016
3	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2020 - 01/2019
3	CDAA (Randox)IBA 11/2020 - 06/2013
3	Indicators and Reagents (Reagents)IBA 05/2020 - 01/2018
3	Gemcitabine FDA Link 01/2020 - 12/2011
3	Illicit Drugs (Recreational Drugs)IBA 01/2015 - 06/2005
2	Lactic Acid (Lactate)FDA LinkGeneric 05/2022 - 04/2004
2	istradefyllineIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2017
2	trifluridine tipiracil drug combinationIBA 12/2020 - 01/2017
2	Cell-Free Nucleic AcidsIBA 03/2020 - 03/2018
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2018
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2016
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019 - 01/2017
2	EnzymesIBA 01/2018 - 03/2016
2	Tolvaptan FDA Link 07/2017 - 01/2016
2	Vitamin A (Retinol)FDA LinkGeneric 01/2017 - 08/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 11/2003
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2016 - 01/2015
2	CreatinineIBA 10/2016 - 01/2016
2	Designer DrugsIBA 05/2014 - 04/2008
2	Nonprescription Drugs (Patent Medicines)IBA 09/2013 - 01/2008
2	Psychotropic Drugs (Psychoactive Drugs)IBA 10/2012 - 04/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	CinnamatesIBA 05/2022
1	trastuzumab deruxtecanIBA 04/2022
1	Albumin-Bound Paclitaxel FDA Link 04/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	RamucirumabIBA 04/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 09/2021
1	FructoseIBA 09/2021
1	Fenofibrate (CiL)FDA LinkGeneric 09/2021
1	Islet Amyloid PolypeptideIBA 09/2021
1	RacloprideIBA 01/2021
1	Transcription Factor 3IBA 01/2021
1	AntigensIBA 01/2021
1	NucleotidesIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	CarbohydratesIBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 12/2020

Therapy/Procedure

16	Therapeutics 05/2022 - 12/2011
14	Drug Therapy (Chemotherapy) 04/2022 - 11/2003
7	Secondary Prevention 01/2022 - 06/2009
2	Liver Transplantation 11/2020 - 01/2016
2	Radiotherapy 09/2017 - 02/2017
1	Condoms (Condom) 01/2022
1	Adjuvant Chemotherapy 01/2021
1	Hepatectomy 01/2021
1	Drug Tapering 12/2020